Everest Medicines Limited
HK$18.78
1
+HK$0+0% Friday 08:08
Statistics
Day High
19.28
Day Low
18.62
52W High
32.2
52W Low
14.34
Volume
467,471
Avg. Volume
2,405,490
Mkt Cap
4.1B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
22AugConfirmed
Expected EPS
-1.0914527730999999
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 1952.HK. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Everest Medicines Limited, a biopharmaceutical company, engages in discovery, licensing, clinical development, and commercialization of therapies to address critical unmet medical needs in Greater China and other Asia Pacific markets. Its pipeline products include eleven clinical-stage drug candidates for the treatment of oncology, immunology, cardio-renal, and infectious diseases. Everest Medicines Limited was incorporated in 2017 and is headquartered in Shanghai, China.
Show more...
CEO
Mr. Wei Fu
Employees
476
Country
Hong Kong
ISIN
KYG3224E1061
WKN
000A2QD66